Quarterly report pursuant to Section 13 or 15(d)

Non-Controlling Interests

v3.7.0.1
Non-Controlling Interests
6 Months Ended
Jun. 30, 2017
Noncontrolling Interest [Abstract]  
Non-Controlling Interests
13. Non-Controlling Interests
 
Non-controlling interests in consolidated entities, as recorded on the Condensed Consolidated Balance Sheets are as follows:
 
 
 
As of June 30, 2017
 
($ in thousands)
 
Avenue
 
Coronado SO
 
Mustang
 
Checkpoint
 
JMC
 
Helocyte
 
Cellvation
 
Caelum
 
National Holdings
 
Total
 
NCI equity share
 
$
3,089
 
$
(236)
 
$
47,009
 
$
22,026
 
$
(570)
 
$
(1,677)
 
$
(151)
 
$
(3)
 
$
17,022
 
$
86,509
 
Net loss attributed to non-controlling interests
 
 
(314)
 
 
(7)
 
 
(5,027)
 
 
(6,707)
 
 
(48)
 
 
(599)
 
 
(83)
 
 
(251)
 
 
4,872
 
 
(8,164)
 
Non-controlling interests in consolidated entities
 
$
2,775
 
$
(243)
 
$
41,982
 
$
15,319
 
$
(618)
 
$
(2,276)
 
$
(234)
 
$
(254)
 
$
21,894
 
$
78,345
 
 
 
 
As of December 31, 2016
 
($ in thousands)
 
Avenue
 
Coronado SO
 
Mustang
 
Checkpoint
 
JMC
 
Helocyte
 
Cellvation
 
National Holdings
 
Total
 
NCI equity share
 
$
(494)
 
$
(217)
 
$
12,376
 
$
32,160
 
$
(192)
 
$
(612)
 
$
4
 
$
17,643
 
$
60,668
 
Net loss attributed to non-controlling interests
 
 
(349)
 
 
(19)
 
 
(1,805)
 
 
(11,733)
 
 
(355)
 
 
(1,155)
 
 
(158)
 
 
(621)
 
 
(16,195)
 
Non-controlling interests in consolidated entities
 
$
(843)
 
$
(236)
 
$
10,571
 
$
20,427
 
$
(547)
 
$
(1,767)
 
$
(154)
 
$
17,022
 
$
44,473
 
 
The components of non-controlling interests in loss of consolidated entities, as recorded on the Condensed Consolidated Statement of Operations are as follows:
 
 
 
For the three months ended June 30, 2017
 
 
 
 
($ in thousands)
 
Avenue
 
Coronado SO
 
Mustang
 
Checkpoint (1)
 
JMC
 
Helocyte
 
Cellvation
 
Caelum
 
National Holdings
 
Total
 
Non-controlling interests in loss of consolidated entities
 
$
(246)
 
$
(3)
 
$
(3,353)
 
$
(3,972)
 
$
20
 
$
(276)
 
$
(30)
 
$
(106)
 
$
2,382
 
$
5,584
 
Non-controlling ownership (3)
 
 
10.2
%
 
13.0
%
 
52.0
%
 
62.4
%
 
7.0
%
 
20.0
%
 
22.0
%
 
25.5
%
 
43.4
 
 
 
 
 
 
 
For the three months ended June 30, 2016
 
($ in thousands)
 
Avenue
 
Coronado SO
 
Mustang
 
Checkpoint
 
 
JMC
 
Helocyte
 
Total
 
Non-controlling interests in loss of consolidated entities
 
$
(76)
 
$
(5)
 
$
(89)
 
$
(3,476)
 
 
$
(108)
 
$
(157)
 
$
(3,911)
 
Non-controlling ownership (3)
 
 
11.5
%
 
13.0
%
 
10.0
%
 
64.3
%
 
 
8.1
%
 
20.4
%
 
 
 
 
 
 
For the six months ended June 30, 2017
 
($ in thousands)
 
Avenue
 
Coronado SO
 
Mustang
 
Checkpoint (1)
 
JMC
 
Helocyte
 
Cellvation
 
Caelum
 
National Holdings
 
Total
 
Non-controlling interests in loss of consolidated entities
 
$
(314)
 
$
(7)
 
$
(5,027)
 
$
(6,707)
 
$
(48)
 
$
(599)
 
$
(83)
 
$
(251)
 
$
4,872
 
$
(8,164)
 
Non-controlling ownership (3)
 
 
10.2
%
 
13.0
%
 
60.8
%
 
61.6
%
 
7.3
%
 
20.0
%
 
22.0
%
 
25.5
%
 
43.4
%
 
 
 
 
 
 
For the six months ended June 30, 2016
 
($ in thousands)
 
Avenue
 
Coronado SO
 
Mustang
 
Checkpoint
 
JMC
 
Helocyte
 
Total
 
Non-controlling interests in loss of consolidated entities
 
$
(184)
 
$
(10)
 
$
(159)
 
$
(7,513)
 
$
(229)
 
$
(254)
 
$
(8,349)
 
Non-controlling ownership (3)
 
 
11.5
%
 
13.0
%
 
10.0
%
 
64.3
%(1)
 
8.1
%
 
20.4
%
 
 
 
 
(1)
- Checkpoint is consolidated with Fortress’s operations because Fortress maintains voting control through its ownership of Checkpoint’s Class A common shares which provide for super-majority voting rights.
(2)
- Mustang and Avenue are consolidated with Fortress’s operations because Fortress maintains voting control through its ownership of Mustang’s Class A preferred shares which provide super-majority voting rights  .
(3)
- Represents a weighted average of ownership during the periods presented.